Bharat Biotech
https://www.bharatbiotech.com/
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Bharat Biotech
Will AZ Legal Notice, Clotting Incidents Cloud Serum’s Fortunes?
AstraZeneca has sent a legal notice to Indian partner Serum Institute for non-delivery of COVID-19 vaccines. Will this and the entry of a new challenger, Sputnik V, in the Indian market affect Serum’s fortunes? Will the EMA and MHRA announcement on clotting incidents related to the AZ vaccine shrink demand for the partnered vaccine?
Coronavirus Update: CoVIg-19 Alliance Ends As Trial Misses Endpoints
Global research consortium to investigate the use of immunoglobulin as a COVID-19 therapy ends following disappointing results from a Phase III trial. Meanwhile, Russian vaccine producer RDIF is snapping up more production capacity in India, where interferon has also progressed as a possible treatment.
Coronavirus Update: Double-Mutant Strain Discovered, India Puts Temporary Hold On AZ Vaccine Exports
Concern in India as a double-mutant strain with E484Q and L452R escape mutations has been found in the state of Maharashtra.
Let The Games Begin, Says COVID-19 Vaccine Quad Alliance
A COVID-19 vaccine alliance between US, Japan, India and Australia announced funding for Johnson & Johnson’s vaccine made by Biological E. Will the arrangement be extended to other vaccines and will the alliance push US to address materials export concerns, recently raised by Serum Institute?
Company Information
- Industry
-
Pharmaceuticals
- Vaccines
-
Biotechnology
- Drug Discovery Tools
- Other Names / Subsidiaries
-
- Chiron Behring Vaccines Pvt Ltd